Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

U.S. Pharma Industry Analysis

UpdatedMay 05, 2025
DataAggregated Company Financials
Companies301
  • 7D-1.5%
  • 3M-3.0%
  • 1Y-2.9%
  • YTD-0.5%

Over the last 7 days, the Pharma industry has dropped 1.5%, driven by a pullback from Eli Lilly of 6.1%. Over the last year, the industry has been flat overall. Earnings are forecast to grow by 15% annually.

Industry Valuation and Performance

Has the U.S. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 05 May 2025US$1.8tUS$382.7bUS$63.7b17.2x27.8x4.6x
Wed, 02 Apr 2025US$1.9tUS$380.6bUS$41.2b16.2x45.2x4.9x
Fri, 28 Feb 2025US$1.9tUS$381.0bUS$39.4b16.4x49.1x5.1x
Sun, 26 Jan 2025US$1.8tUS$370.4bUS$30.5b18.4x59.1x4.9x
Tue, 24 Dec 2024US$1.8tUS$369.4bUS$31.1b16.7x57.2x4.8x
Thu, 21 Nov 2024US$1.8tUS$373.8bUS$30.6b20.1x58.1x4.7x
Sat, 19 Oct 2024US$2.0tUS$365.3bUS$23.7b18.6x85.8x5.6x
Mon, 16 Sep 2024US$2.0tUS$364.3bUS$25.4b18.8x80.2x5.6x
Wed, 14 Aug 2024US$2.0tUS$362.1bUS$22.0b17.4x89x5.4x
Fri, 12 Jul 2024US$2.0tUS$357.6bUS$13.8b15.9x144.8x5.6x
Sun, 09 Jun 2024US$1.9tUS$358.3bUS$14.1b15.6x136.8x5.4x
Tue, 07 May 2024US$1.8tUS$358.0bUS$13.8b21.1x133.7x5.1x
Thu, 04 Apr 2024US$1.9tUS$355.2bUS$22.7b24.6x82.9x5.3x
Sat, 02 Mar 2024US$1.9tUS$355.3bUS$22.5b24.1x83.8x5.3x
Mon, 29 Jan 2024US$1.8tUS$375.2bUS$33.9b24.6x52.1x4.7x
Wed, 27 Dec 2023US$1.7tUS$375.2bUS$33.9b31.8x49.3x4.4x
Fri, 24 Nov 2023US$1.6tUS$375.1bUS$33.9b25.9x48.2x4.4x
Sun, 22 Oct 2023US$1.7tUS$382.7bUS$44.7b17.6x37x4.3x
Tue, 19 Sep 2023US$1.7tUS$381.8bUS$43.9b18.5x39.1x4.5x
Thu, 17 Aug 2023US$1.8tUS$381.7bUS$44.0b19.1x40.2x4.6x
Sat, 15 Jul 2023US$1.7tUS$392.8bUS$60.2b18.3x27.7x4.2x
Mon, 12 Jun 2023US$1.7tUS$393.0bUS$60.5b18.6x28.4x4.4x
Wed, 10 May 2023US$1.7tUS$395.1bUS$56.8b19.4x30.7x4.4x
Fri, 07 Apr 2023US$1.7tUS$401.2bUS$69.4b15.9x23.8x4.1x
Sun, 05 Mar 2023US$1.6tUS$401.2bUS$69.4b16.9x22.5x3.9x
Tue, 31 Jan 2023US$1.6tUS$402.6bUS$69.4b17.8x23.7x4.1x
Thu, 29 Dec 2022US$1.7tUS$403.7bUS$70.7b16.6x24.6x4.3x
Sat, 26 Nov 2022US$1.7tUS$403.7bUS$70.7b16.9x24.7x4.3x
Mon, 24 Oct 2022US$1.6tUS$403.4bUS$72.1b13.2x22.5x4x
Wed, 21 Sep 2022US$1.6tUS$403.0bUS$71.3b13.1x21.8x3.9x
Fri, 19 Aug 2022US$1.6tUS$402.8bUS$70.2b15.8x23.4x4.1x
Sun, 17 Jul 2022US$1.7tUS$392.4bUS$65.1b22x26.1x4.3x
Tue, 14 Jun 2022US$1.6tUS$392.5bUS$64.7b19.9x24.3x4x
Thu, 12 May 2022US$1.6tUS$392.3bUS$64.5b19.1x24.9x4.1x
Price to Earnings Ratio

24.9x


Total Market Cap: US$1.6tTotal Earnings: US$64.5bTotal Revenue: US$392.3bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Pharma Industry Price to Earnings3Y Average 51.9x202320242025
Current Industry PE
  • Investors are pessimistic on the American Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 27.8x which is lower than its 3-year average PE of 51.9x.
  • The industry is trading close to its 3-year average PS ratio of 4.6x.
Past Earnings Growth
  • Both revenue and earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • This means that sales and the cost of doing business have remained relatively consistent over this period and subsequently, so have profits.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market2.79%
Healthcare0.20%
Pharma-1.49%
Pharma-1.49%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PFE PfizerUS$24.205.0%
+US$6.5b		-14.1%PE17.4x
BMY Bristol-Myers SquibbUS$50.574.4%
+US$4.3b		15.2%PE19x
JNJ Johnson & JohnsonUS$156.120.5%
+US$1.9b		5.1%PE17.2x
ZTS ZoetisUS$157.442.5%
+US$1.7b		-5.1%PE28.2x
TEVA Teva Pharmaceutical IndustriesUS$16.197.8%
+US$1.3b		15.1%PS1.1x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

LLY

US$823.62

Eli Lilly

7D

-6.1%

1Y

7.4%

Eli Lilly and Company Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

May 05
Eli Lilly and Company Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

MRK

US$83.18

Merck

7D

-0.01%

1Y

-34.8%

OGN

US$9.59

Organon

7D

-24.6%

1Y

-53.6%

Organon's (NYSE:OGN) Dividend Is Being Reduced To $0.02

May 04
Organon's (NYSE:OGN) Dividend Is Being Reduced To $0.02

PHAT

US$2.76

Phathom Pharmaceuticals

7D

-33.5%

1Y

-74.5%

ARVN

US$7.72

Arvinas

7D

-16.2%

1Y

-76.1%

TARS

US$47.36

Tarsus Pharmaceuticals

7D

-4.7%

1Y

27.9%

JNJ

US$156.12

Johnson & Johnson

7D

0.5%

1Y

5.1%

Johnson & Johnson (NYSE:JNJ) Is Increasing Its Dividend To $1.30

May 02
Johnson & Johnson (NYSE:JNJ) Is Increasing Its Dividend To $1.30

SIGA

US$5.63

SIGA Technologies

7D

-11.3%

1Y

-45.8%

VRNA

US$72.73

Verona Pharma

7D

5.7%

1Y

386.5%

This Just In: Analysts Are Boosting Their Verona Pharma plc (NASDAQ:VRNA) Outlook for This Year

May 01
This Just In: Analysts Are Boosting Their Verona Pharma plc (NASDAQ:VRNA) Outlook for This Year

PCRX

US$26.45

Pacira BioSciences

7D

-2.5%

1Y

-0.2%

ZTS

US$157.44

Zoetis

7D

2.5%

1Y

-5.1%

Zoetis Inc.'s (NYSE:ZTS) Intrinsic Value Is Potentially 41% Above Its Share Price

Apr 30
Zoetis Inc.'s (NYSE:ZTS) Intrinsic Value Is Potentially 41% Above Its Share Price

PFE

US$24.20

Pfizer

7D

5.0%

1Y

-14.1%

Pfizer's Q1 Update May Mark A Bottom In The Stock

Apr 30

JAZZ

US$120.05

Jazz Pharmaceuticals

7D

6.3%

1Y

9.3%

Does Jazz Pharmaceuticals (NASDAQ:JAZZ) Deserve A Spot On Your Watchlist?

Apr 27
Does Jazz Pharmaceuticals (NASDAQ:JAZZ) Deserve A Spot On Your Watchlist?

BMY

US$50.57

Bristol-Myers Squibb

7D

4.4%

1Y

15.2%

TEVA

US$16.19

Teva Pharmaceutical Industries

7D

7.8%

1Y

15.1%

author-image

Generics And Biosimilars Pipeline And Expansion Will Define Progress

Apr 23 The Pivot to Growth strategy targets revenue enhancement through product innovation, operational efficiency, and a sustainable generics business.

VTRS

US$8.65

Viatris

7D

4.8%

1Y

-26.8%

author-image

New Product Launches And Expense Savings Will Strengthen Future Operations

Apr 22 New product launches and late-stage developments are expected to drive future revenue growth and improve net margins through higher-margin innovations.